Zydus Hospira Oncology Private Limited Gemcitabine Export Data — India (DGFT 2022–2026)

Name: Zydus Hospira Oncology Private Limited Gemcitabine Export Records India — #8 Exporter, 42 Shipments, $2.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Gemcitabine

India Pharmaceutical Trade Intelligence

$46.5M248 Suppliers125 CountriesHS 30049049

ExportsIndia → UNITED STATES16.8%India → BELGIUM12.7%

ImportsUNITED STATES → India$133.8M FRANCE → India$35.5M

#1 Supplier: FRESENIUS KABI #1 Buyer: YUSEN LOGISTICS

Zydus Hospira Oncology Private Limited — Gemcitabine Exporter #8 | $2.1M Trade Value | TransData Nexus | TransData Nexus

Zydus Hospira Oncology Private Limited — Gemcitabine Exporter Profile

Indian Pharmaceutical Exporter · #8 for Gemcitabine · $2.1M export value · DGFT Verified

Zydus Hospira Oncology Private Limited is the #8 Indian exporter of Gemcitabine with $2.1M in export value and 42 verified shipments. Zydus Hospira Oncology Private Limited holds a 4.5% market share in Gemcitabine exports across 9 countries. The company exports 5 pharmaceutical products worth $4.7M across 2 therapeutic categories.

Zydus Hospira Oncology Private Limited — Gemcitabine Export Profile: Buyers & Destinations

Zydus Hospira Oncology Private Limited Gemcitabine export treemap — buyers and destination countries | TransData Nexus

Where Does Zydus Hospira Oncology Private Limited Export Gemcitabine?

Country	Value	Shipments	Share
UNITED STATES OF AMERICA	$509.3K	11	35.2%
UNITED STATES	$390.7K	8	27.0%
BELGIUM	$263.3K	8	18.2%
AUSTRALIA	$200.0K	4	13.8%

Who Are the Top Buyers of Gemcitabine from Zydus Hospira Oncology Private Limited?

Buyer	Country	Value	Orders
XXIZEXXSERXXCE XXMPAXX BV	CZECH REPUBLIC	$779.5K	24
PFIZER SERVICE COMPANY BV	HONG KONG	$517.7K	15
HOSPIRA INC	UNITED STATES	$100.0K	2
XXDUSXXIFEXXIENXXS LXX (XXRMEXXY KXXWN XX CAXXLA	ALGERIA	$50.0K	1

Zydus Hospira Oncology Private Limited supplies Gemcitabine to 4 buyers globally. The largest buyer is XXIZEXXSERXXCE XXMPAXX BV (CZECH REPUBLIC), followed by PFIZER SERVICE COMPANY BV (HONG KONG) and HOSPIRA INC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Gemcitabine Formulations Does Zydus Hospira Oncology Private Limited Export?

Product Description / Formulation	Value	Shipments
GEMCITABINE INJECTION 2G US-F000206913	$481.5K	10
GEMCITABINE INJ. 2G AU/NZ - F000046485	$200.0K	4
GEMCITABINE INJ. 200MG US - F000206916	$118.5K	3
GEMCITABINE INJ.2G-BR-H000205209	$110.7K	7
GEMCITABINE INJECTION 1G US-F000206903	$100.0K	2
ZYGEM 1G INJECTION (GEMCITABINE	$50.0K	1
GEMCITABINE INJ. 1G US N+ F000206904	$50.0K	1
GEMCITABINE INJ.200MG-ES-F000057726	$50.0K	1
GEMCITABINE FOR INJ. 2G US-F000206930	$50.0K	1
GEMCITABINE FOR INJ. 1G US-F000206928	$50.0K	1

Zydus Hospira Oncology Private Limited exports 21 distinct Gemcitabine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is GEMCITABINE INJECTION 2G US-F000206913 with 10 shipments worth $481.5K.

How Does Zydus Hospira Oncology Private Limited Compare to Nearest Gemcitabine Exporters?

Exporters ranked immediately above and below #8 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
6	ACCURE LABS PRIVATE LIMITED	$3.1M	107	2	$29.0K
9	VENUS REMEDIES LIMITED	$2.2M	189	23	$11.6K
8	ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED ★	$2.1M	42	9	$50.0K
7	JODAS EXPOIM PRIVATE LIMITED	$1.8M	35	2	$50.0K
4	MYLAN LABORATORIES LIMITED	$1.6M	32	1	$50.0K

Zydus Hospira Oncology Private Limited ranks #8 among 248 Indian Gemcitabine exporters. Average shipment value of $50.0K compared to the market average of $147.4K. The closest competitors by value are ACCURE LABS PRIVATE LIMITED and VENUS REMEDIES LIMITED.

Which Indian Ports Ship Gemcitabine Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	538	18.3%
SAHAR AIR CARGO ACC (INBOM4)	393	13.4%
SAHAR AIR	370	12.6%
DELHI AIR	358	12.2%
Delhi Air	131	4.5%
HYDERABAD ICD (INSNF6)	88	3.0%
Bombay Air	77	2.6%
NHAVA SHEVA SEA (INNSA1)	66	2.2%

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Gemcitabine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Zydus Hospira Oncology Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 42 individual customs records matching Zydus Hospira Oncology Private Limited exporting Gemcitabine, covering 21 formulations to 10 countries via 4 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 125+ countries, 676+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Gemcitabine

Gemcitabine

Zydus Hospira Oncology Private Limited — Gemcitabine Exporter Profile

Zydus Hospira Oncology Private Limited — Gemcitabine Export Profile: Buyers & Destinations

Where Does Zydus Hospira Oncology Private Limited Export Gemcitabine?

Who Are the Top Buyers of Gemcitabine from Zydus Hospira Oncology Private Limited?

What Is India's Total Gemcitabine Export Value and How Much Does Zydus Hospira Oncology Private Limited Contribute?

What Is the Average Shipment Value for Zydus Hospira Oncology Private Limited's Gemcitabine Exports?

How Does Zydus Hospira Oncology Private Limited Compare to Other Indian Gemcitabine Exporters?

What Gemcitabine Formulations Does Zydus Hospira Oncology Private Limited Export?

Regulatory Requirements: Exporting Gemcitabine to Key Markets

United States — FDA

How Does Zydus Hospira Oncology Private Limited Compare to Nearest Gemcitabine Exporters?

Which Indian Ports Ship Gemcitabine Exports?

What Other Oncology Products Does Zydus Hospira Oncology Private Limited Export?

About Zydus Hospira Oncology Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Gemcitabine Export Data from Zydus Hospira Oncology Private Limited

Gemcitabine Stats

Company Overview

Top Products by Zydus Hospira Oncology Private Limited

Related Analysis

Need Detailed Export Data?

Data Source